Basic and clinical science posters: Brain function

Basic and clinical science posters: Brain function P49 Recurrent hypoglycaemia increases human primary astrocyte oxygen consumption, fatty acid dependency, and pentose phosphate pathway activityPG WEIGHTMAN POTTER1, JM Vlachaki Walker1, JL Robb1, J Chilton1, R Williamson2, A Randall3, KLJ Ellacott1, C Beall11Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, UK, 2School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK, 3Institute of Biomedical and Clinical Sciences, Hatherly Laboratories, University of Exeter Medical School, Exeter, UKRefer to Oral number A64P50Alzheimer's disease drug Memantine inhibits Adenosine triphosphate (ATP)‐sensitive potassium (KATP) channel activation in hypothalamic GT1‐7 cellsBC HALL1,2, C Beall1,2, AD Randall11Hatherly Laboratories, University of Exeter, Exeter, UK, 2Exeter Medical School, University of Exeter, Exeter, UKAims: KATP channels link cellular energy status to electrical activity in a variety of cell types, including pancreatic beta cells and neurons. In the brain, KATP channels are expressed abundantly in the hypothalamus, playing important roles in the regulation of energy metabolism. Memantine (Mem) is an uncompetitive weak N‐methyl‐D‐aspartate receptor (NMDA) antagonist used to treat Alzheimer's disease. Mem was recently reported to block recombinant KATP channels in the 10‐nM concentration range. This activity was suggested to contribute to Mem's therapeutic efficacy via actions at central nervous system (CNS) synapses. We have investigated the effect of Mem on the endogenous KATP channel conductance in the hypothalamic GT1‐7 cell line.Methods: Patch‐clamp electrophysiology at RT was used to examine whole cell currents after the cell had been dialysed with an ATP‐free pipette solution (ensuring KATP channels were maximally open, termed run‐up), Mem was applied via the perfusate.Results: Application of 100μM Mem after run‐up produced a significant reduction in whole‐cell leak conductance compared with vehicle (G/Gmax: Veh 0.86 ± 0.13 (n = 6), 100μM 0.38 ± 0.18 (n = 6), p < 0.05). Similarly, when Mem (100μM) was applied prior to ATP washout, a significant reduction in maximal conductance was observed at run‐up (nS/pF: Veh 1.06 ± 0.05 (n = 25), Mem 100μM 0.41 ± 0.02 (n = 7), p < 0.001). In both experimental protocols, neither 1μM nor 10μM Mem caused any significant reduction in leak current conductance compared with vehicle.Summary: Memantine reduces the leak conductance elicited by ATP washout in GT1‐7 cells; however, this is weak activity only being ˜60% complete at 100μM. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Diabetic Medicine Wiley

Basic and clinical science posters: Brain function

Free
1 page

Loading next page...
1 Page
 
/lp/wiley/basic-and-clinical-science-posters-brain-function-kbLM8X5ETi
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Diabetic Medicine © 2018 Diabetes UK
ISSN
0742-3071
eISSN
1464-5491
D.O.I.
10.1111/dme.4_13571
Publisher site
See Article on Publisher Site

Abstract

P49 Recurrent hypoglycaemia increases human primary astrocyte oxygen consumption, fatty acid dependency, and pentose phosphate pathway activityPG WEIGHTMAN POTTER1, JM Vlachaki Walker1, JL Robb1, J Chilton1, R Williamson2, A Randall3, KLJ Ellacott1, C Beall11Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, UK, 2School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK, 3Institute of Biomedical and Clinical Sciences, Hatherly Laboratories, University of Exeter Medical School, Exeter, UKRefer to Oral number A64P50Alzheimer's disease drug Memantine inhibits Adenosine triphosphate (ATP)‐sensitive potassium (KATP) channel activation in hypothalamic GT1‐7 cellsBC HALL1,2, C Beall1,2, AD Randall11Hatherly Laboratories, University of Exeter, Exeter, UK, 2Exeter Medical School, University of Exeter, Exeter, UKAims: KATP channels link cellular energy status to electrical activity in a variety of cell types, including pancreatic beta cells and neurons. In the brain, KATP channels are expressed abundantly in the hypothalamus, playing important roles in the regulation of energy metabolism. Memantine (Mem) is an uncompetitive weak N‐methyl‐D‐aspartate receptor (NMDA) antagonist used to treat Alzheimer's disease. Mem was recently reported to block recombinant KATP channels in the 10‐nM concentration range. This activity was suggested to contribute to Mem's therapeutic efficacy via actions at central nervous system (CNS) synapses. We have investigated the effect of Mem on the endogenous KATP channel conductance in the hypothalamic GT1‐7 cell line.Methods: Patch‐clamp electrophysiology at RT was used to examine whole cell currents after the cell had been dialysed with an ATP‐free pipette solution (ensuring KATP channels were maximally open, termed run‐up), Mem was applied via the perfusate.Results: Application of 100μM Mem after run‐up produced a significant reduction in whole‐cell leak conductance compared with vehicle (G/Gmax: Veh 0.86 ± 0.13 (n = 6), 100μM 0.38 ± 0.18 (n = 6), p < 0.05). Similarly, when Mem (100μM) was applied prior to ATP washout, a significant reduction in maximal conductance was observed at run‐up (nS/pF: Veh 1.06 ± 0.05 (n = 25), Mem 100μM 0.41 ± 0.02 (n = 7), p < 0.001). In both experimental protocols, neither 1μM nor 10μM Mem caused any significant reduction in leak current conductance compared with vehicle.Summary: Memantine reduces the leak conductance elicited by ATP washout in GT1‐7 cells; however, this is weak activity only being ˜60% complete at 100μM.

Journal

Diabetic MedicineWiley

Published: Jan 1, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off